Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 13, 2018 07:30 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences to Host Institutional Investor and Analyst Day on Friday, October 5, 2018

RALEIGH, N.C., Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
September 10, 2018 08:00 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference

RALEIGH, N.C., Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial stage specialty pharmaceutical company dedicated to patients living...
August 30, 2018 14:53 ET | Source: Sen-Jam Pharmaceutical

Sen-Jam Pharmaceutical Reports the Positive Effect of Payer Options and Expanded Coverage for Individuals with Opioid Use Disorder

HUNTINGTON, N.Y., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Opioid Epidemic is an incredibly complex and multifaceted problem facing America. We wanted to investigate the developments in medications,...
August 28, 2018 16:31 ET | Source: Emergent BioSolutions

Emergent BioSolutions Joins Effort to Combat National Public Health Threat From Opioid Overdose Through Acquisition of Adapt Pharma and Its Flagship Product NARCAN® (naloxone HCl) Nasal Spray

Acquisition advances Emergent’s mission, vision and strategic growth plan by: Diversifying and expanding company’s presence within the public health threats market to respond to the opioid crisis,...
August 27, 2018 09:01 ET | Source: Addiction Policy Forum

Addiction Policy Forum Launches Overdose Reversal Toolkit in Collaboration with University of Waterloo

Washington, DC, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Today Addiction Policy Forum released a free, comprehensive Overdose Reversal Toolkit in collaboration with the University of Waterloo School of...
August 21, 2018 08:00 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

RALEIGH, N.C., Aug. 21, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with...
August 15, 2018 09:26 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Secures Significant Expanded Preferred Coverage for BELBUCA®

RALEIGH, N.C., Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with...
August 09, 2018 16:05 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Reports Strong Second Quarter 2018 Financial Results

BELBUCA® Continues Its Accelerated Record Prescription Growth of 80% YOY and 31% Versus the Prior Quarter Company Provides Overview of New Plan to Capitalize on Long Term Net Revenue Potential of...
August 08, 2018 16:15 ET | Source: INSYS Therapeutics, Inc.

INSYS Therapeutics Reports Second Quarter 2018 Results

PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids (CBD) and spray...
August 02, 2018 06:00 ET | Source: Aegis Therapeutics LLC

Aegis Expands its International and US Intravail® Patent Portfolio on Multiple Fronts

SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded European Patent No. EP2381773(B1) and Canadian Patent No. 2,748,268, providing fast...